Evaluation of Response to Atezolizumab Plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma Using the Combination of Response Evaluation Criteria in Solid Tumors and Alpha-Fetoprotein.

Cancers (Basel) · 2023 · PMC10137288 · PMID 37190231

Europe PMC DOI

hedged sentence

0.0590

closest p · 1.2× alpha

0.0590

boldest claim

The sentences

close to significancep = 0.059so close (0.05 < p ≤ 0.1)

There was close to significance of the rate of PD at the second radiological response evaluation ( p = 0.059).

also in 610 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.